Biblio
Export 1081 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is T [Clear All Filters]
“Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.”, J Alzheimers Dis, vol. 90, no. 1, pp. 295-303, 2022.
, “The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults.”, J Alzheimers Dis, vol. 60, no. 3, pp. 913-921, 2017.
, “Relationship of Area of Soft Drusen in Retina with Cerebral Amyloid-β Accumulation and Blood Amyloid-β Level in the Elderly.”, J Alzheimers Dis, vol. 62, no. 1, pp. 239-245, 2018.
, “Relationship Between Weight-Change Patterns and Cognitive Function: A Retrospective Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1085-1095, 2022.
, “The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults.”, J Alzheimers Dis, vol. 88, no. 2, pp. 521-535, 2022.
, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.
, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
, “Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”, J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
, “Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 533-549, 2018.
, “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
, “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
, “Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”, J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
, “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
, “Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
, “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
, “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
, “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
, “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
, “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
, “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
, “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
,